This is an old revision of this page, as edited by BogBot (talk | contribs) at 11:02, 3 September 2011 (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 11:02, 3 September 2011 by BogBot (talk | contribs) (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
Other names | 2-amino]guanidine |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.121.515 |
Chemical and physical data | |
Formula | C5H12N8 |
Molar mass | 184.20 g/mol g·mol |
(verify) |
Mitoguazone (also known as methylglyoxal bis(guanylhydrazone) or MGBG) is a drug used in chemotherapy.
This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it. |